Monopar Therapeutics: Oppenheimer starts coverage on Outperform, $77 price target.

Wednesday, Sep 3, 2025 12:46 pm ET1min read

Monopar Therapeutics: Oppenheimer starts coverage on Outperform, $77 price target.

Comments



Add a public comment...
No comments

No comments yet